SB 233

Abstract

Creates the MRSA Screening and Reporting Act and amends the Hospital Licensing Act. Requires every hospital to establish a methicillin-resistant Staphylococcus aureus (MRSA) control program, and sets forth items that must be included in such a program. Provides that for all hospital patients who are identified with nosocomial S. aureus bloodstream infection or asymptomatic colonization due to MRSA, the Department of Public Health shall require the annual reporting of such cases as a communicable disease or condition. Requires the Department to compile aggregate data from all hospitals for all such patients and to make such data available on its website and in all reports on health statistics and reportable communicable disease cases in Illinois. In provisions of the Hospital Licensing Act concerning the reporting of communicable reportable diseases and conditions, provides that after the effective date of the amendatory Act, such reportable diseases and conditions shall include nosocomial Staphylococcus aureus bloodstream infections and asymptomatic colonization due to MRSA.